1 1 Clonal structure, extended-spectrum β-lactamases and acquired AmpC- 2 type cephalosporinases of Escherichia coli populations colonizing patients in 3 rehabilitation centers in four countries. 4 R. Izdebski 1± , A. Baraniak 1± , J. Fiett 1 , A. Adler 2 , M. Kazma 2 , J. Salomon 3 , C. Lawrence 4 , A. 5 Rossini 5 , A. Salvia 5 , J. Vidal Samso 6 , J. Fierro 6 , M. Paul 7 , Y. Lerman 8 , S. Malhotra-Kumar 9 , 6 C. Lammens 9 , H. Goossens 9 , W. Hryniewicz 1 , C. Brun-Buisson 10 , Y. Carmeli 2 , 7 and M. Gniadkowski 1* on behalf of the MOSAR WP2 & WP5 study groups † 8 9 1 National Medicines Institute, Warsaw, Poland 10 2 Division of Epidemiology and Preventive Medicine, Tel-Aviv Sourasky Medical Center, 11 Tel-Aviv, Israel 12 3 INSERM, Institut Pasteur, Cnam, Paris, France 13 4 Hôpital Maritime de Berck, Berck/Garches/Paris, France 14 5 Fondazione Santa Lucia IRCCS, Rome, Italy 15 6 Institute Guttmann, Barcelona, Spain 16 7 Loewenstein Hospital, Ra’anana, Israel 17 8 Geriatric Division, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel 18 9 University of Antwerp, Antwerp, Belgium 19 10 INSERM, U957 & Université Paris-Est, Créteil, France 20 21 Key words: Escherichia coli, population study, MLST, ESBL, AmpC 22 23 * Corresponding author: 24 Marek Gniadkowski, National Medicines Institute, ul. Chełmska 30/34, 00-725 Warsaw, 25 Poland. Fax: (+48) 22 - 841 29 49. E-mail: gniadkow@cls.edu.pl 26 27 ± these authors contributed equally to this work 28 29 † apart from the authors listed above, the MOSAR WP2 & WP5 study groups included: 30 A. Grabowska, M. Herda, E. Nikonorow – National Medicines Institute, Warsaw, Poland; M. 31 J. Schwaber, E. Bilavsky, M. Elenbogen, A. Klein, S. Navon-Venezia, M. Shklyar, L. Keren, 32 R. Glick, S. Klarfeld-Lidji, E. Mordechai, S. Cohen, R. Fachima, Y. Zdonevsky, B. 33 Knubovets – Division of Epidemiology and Preventive Medicine, Tel-Aviv Sourasky Medical 34 Center, Tel Aviv, Israel; J. Lasley, I. Bertucci, M.-L. Delaby, C. Colmant, C. Sacleux – 35 Hôpital Maritime de Berck, Berck/Garches/Paris, France; R. Formisano, M. P. Balice, E. 36 Guaglianone – Fondazione Santa Lucia IRCCS, Rome, Italy; S. Camps – Institute Guttmann, 37 Barcelona, Spain; J. Hart, E. Isakov, A. Friedman, A. Rachman, G. Franco, I. Or – 38 Loewenstein Hospital, Ra’anana, Israel; A. Rabinovich – Geriatric Division, Tel-Aviv 39 Sourasky Medical Center, Tel-Aviv, Israel. 40 41 Copyright © 2012, American Society for Microbiology. All Rights Reserved. Antimicrob. Agents Chemother. doi:10.1128/AAC.01656-12 AAC Accepts, published online ahead of print on 31 October 2012 on November 3, 2017 by guest http://aac.asm.org/ Downloaded from